NO994750L - Anti-Fas-antistoffer - Google Patents

Anti-Fas-antistoffer

Info

Publication number
NO994750L
NO994750L NO994750A NO994750A NO994750L NO 994750 L NO994750 L NO 994750L NO 994750 A NO994750 A NO 994750A NO 994750 A NO994750 A NO 994750A NO 994750 L NO994750 L NO 994750L
Authority
NO
Norway
Prior art keywords
fas
fas antibodies
antibodies
abnormalities
mouse
Prior art date
Application number
NO994750A
Other languages
English (en)
Norwegian (no)
Other versions
NO994750D0 (no
Inventor
Nobufusa Serizawa
Hideyuki Haruyama
Kaori Nakahara
Ikuko Tamaki
Tohru Takahashi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO994750D0 publication Critical patent/NO994750D0/no
Publication of NO994750L publication Critical patent/NO994750L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO994750A 1998-09-30 1999-09-29 Anti-Fas-antistoffer NO994750L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27688198 1998-09-30
JP27688298 1998-09-30

Publications (2)

Publication Number Publication Date
NO994750D0 NO994750D0 (no) 1999-09-29
NO994750L true NO994750L (no) 2000-03-31

Family

ID=26552152

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994750A NO994750L (no) 1998-09-30 1999-09-29 Anti-Fas-antistoffer

Country Status (14)

Country Link
EP (1) EP0990663A3 (fr)
KR (1) KR20000023549A (fr)
CN (1) CN1266714A (fr)
AR (1) AR023333A1 (fr)
AU (1) AU757961B2 (fr)
BR (1) BR9904475A (fr)
CA (1) CA2283540A1 (fr)
HU (1) HUP9903299A3 (fr)
ID (1) ID25978A (fr)
IL (1) IL132139A0 (fr)
NO (1) NO994750L (fr)
NZ (1) NZ500019A (fr)
PL (1) PL335752A1 (fr)
RU (1) RU2223115C2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1087993B1 (fr) 1998-06-18 2008-04-02 Imed Ab Peptides et anticorps fas pour moduler l'apoptose
JP4907843B2 (ja) 2002-03-25 2012-04-04 公益財団法人ひろしま産業振興機構 ヒト肝細胞増殖方法とヒト肝細胞の取得方法
AU2004319915B9 (en) * 2004-04-22 2011-12-22 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
WO2006004988A2 (fr) * 2004-06-30 2006-01-12 Mayo Foundation For Medical Education And Research Anticorps se liant a b7-dc
CA2881717C (fr) * 2006-06-06 2018-06-12 Cecilia Anna Wilhelmina Geuijen Molecules de liaison humaines presentant une activite bactericide contre les staphylocoques et leurs utilisations
EP2712930A3 (fr) * 2006-12-06 2014-04-23 MedImmune, LLC Marqueurs pharmacodynamiques par induction alpha d'interféron
UA100255C2 (uk) * 2007-12-28 2012-12-10 Біоінвент Інтернешенл Аб Фармацевтична композиція
CA2742157A1 (fr) * 2008-10-31 2010-05-06 Toray Industries, Inc. Procede d'immunoessai pour la proteine cxcl1 humaine
US8323652B2 (en) 2008-11-14 2012-12-04 Canadian Blood Services Antibodies against GPIbα
RU2519196C2 (ru) * 2011-07-01 2014-06-10 Олег Ильич Эпштейн Лекарственное средство для лечения патологического синдрома и способ лечения рассеянного склероза
TWI595007B (zh) 2012-09-10 2017-08-11 Neotope Biosciences Ltd 抗ｍｃａｍ抗體及相關使用方法
KR20160131082A (ko) * 2014-03-12 2016-11-15 프로테나 바이오사이언시즈 리미티드 Lg1-3에 특이적인 항-라미닌4 항체
JP2017514458A (ja) 2014-03-12 2017-06-08 プロセナ バイオサイエンシーズ リミテッド Ｌｇ４−５に対して特異的な抗−ラミニン４抗体
PT3116911T (pt) 2014-03-12 2019-09-04 Prothena Biosciences Ltd Anticorpos anti-mcam e métodos de utilização associados
MX2018004721A (es) * 2015-10-23 2018-07-06 Eureka Therapeutics Inc Construcciones quimericas anticuerpo/receptor de celulas t y usos de las mismas.
CN111995681B (zh) * 2020-05-09 2022-03-08 华博生物医药技术（上海）有限公司 抗tigit的抗体、其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123756A0 (en) * 1997-03-21 1998-10-30 Sankyo Co Humanized anti-human FAS antibody
IL123888A0 (en) * 1997-04-01 1998-10-30 Sankyo Co Anti-fas antibodies

Also Published As

Publication number Publication date
EP0990663A2 (fr) 2000-04-05
HU9903299D0 (en) 1999-11-29
HUP9903299A3 (en) 2004-05-28
NZ500019A (en) 2001-06-29
NO994750D0 (no) 1999-09-29
AR023333A1 (es) 2002-09-04
PL335752A1 (en) 2000-04-10
BR9904475A (pt) 2000-12-12
AU5016199A (en) 2000-04-13
IL132139A0 (en) 2001-03-19
CN1266714A (zh) 2000-09-20
ID25978A (id) 2000-11-16
EP0990663A3 (fr) 2002-04-17
KR20000023549A (ko) 2000-04-25
HUP9903299A2 (hu) 2000-11-28
AU757961B2 (en) 2003-03-13
CA2283540A1 (fr) 2000-03-30
RU2223115C2 (ru) 2004-02-10

Similar Documents

Publication Publication Date Title
NO994750L (no) Anti-Fas-antistoffer
SG2011076551A (en) Antibodies to opgl
GR3026219T3 (en) Mouse monoclonal antibodies
DE69939864D1 (de) Ppar-gamma modulatoren
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
TR199801390T2 (xx) Tromboz tedavisinde kullan�lacak p�ht�la�may� �nleyici maddeler
NO994486D0 (no) System og fremgangsmÕte for Õ hÕndtere brukertilgang til Internett
GEP20105118B (en) Anti-vegf antibodies
NO20005692D0 (no) Forbedringer i og vedrörende bygningselementer, og fremgangsmåter vedrörende samme
ATE364386T1 (de) (s,s)-reboxetine zur behandlung von chronischen erschöpfungssyndrom
GB2368796A (en) Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
FI965250A0 (fi) Noggrann maetning av koncentration foer en gaskomponent i en gasblandning, i vilken andra komponenter paoverkar koncentrationsbestaemningen
NO970533D0 (no) Blodbehandlingssystem og fremgangsmåte som overvåker citratretur til giveren
NO981454D0 (no) Anti-FAS-antistoffer
IT8467250A1 (it) Copolimero alliloligosaccaride acrilico salificato, procedimento per la sua preparazione e suo impiego come superassorbente.
IS4628A (is) Frumuröð sem myndar kvalastillandi efni til nota í meðferð gegn sársauka
TR200103432T2 (tr) Engelleyici monoklonal VLA-1 antikoru ve enflamasyonlu hastalıkların tedavisinde kullanımı.
ID29614A (id) Metoda penyekatan, aparatus untuk mengatur rapatan aliran cahaya dan aparatus untuk mengatur penyaluran sinar
DE69901076D1 (de) Lineares Trien sowie Copolymer davon
NZ502800A (en) The use of apoptin in determining the transforming capability of tumorigenic or tumor promoting agents
PT1092040E (pt) Metodos de inibicao helicobacter pylori
ATE189897T1 (de) Antikörper gegen das prorenin profragment, reninaktive substanz die diese enthält und prorenintest die diese verwendet
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
DE69529510D1 (de) Pipelineprozessor mit reduzierten Verschränkungen, die von Verzweigungsbefehlen veranlasst werden
ATE40116T1 (de) 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application